SAGA Diagnostics

Personalized cancer medicine and disease monitoring

Investment Q2 2019

About SAGA Diagnostics

SAGA Diagnostics provide molecular genetic tests and services for healthcare, biopharmaceutical companies, and academia. Based on leading research from Lund university, Sweden, they proprietary and patient-pending molecular genetic test are part of a revolution in cancer companion diagnostics and monitoring. SAGA’s tests quantify circular tumor DNA (ctDNA) -a powerful new biomarker -to detect cancer, measure response to therapy, and decipher the cancer-specific DNA mutations that may be targetable with clinically-approved drugs or therapies currently in clinical trials.